In addition to options that address medical nutrition needs, including those associated with surgery, critical illness, and chronic disease, this project will also create products for the active living and high-performance sports markets. The end products will contain a novel plant-based protein ingredient blend with high functionality and taste quality, reformulated from a past project.
The end products will contain a novel plant-based protein ingredient blend with high functionality and taste quality, reformulated from a past project.
Protein Industries Canada will invest $2.3 million into the $5.4 million project; the remaining cost will be shared between Enhanced Medical Nutrition (EMN), Acenzia, and Gruppo Nutrition.
Source : Pembinavalley online